Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 81.45

-1.6%

Dec 29 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (31)	9/17/2002 12:19:10 PM
From: Jibacoa	of 3722

XOMA Opened on a good up-gap today after the early news about Raptiva achieving its primary efficacy endpoint in its trial for moderate-to-severe psoriasis. Serono, which has an exclusive license to market Raptiva outside of the U.S.& Japan,plans to file Raptiva with European authorities in the first quarter of 2003. biz.yahoo.com It seems that XOMA is ready to close its early April down-gap by closing above 7 in the near future. It had a good up-move in the first 20 minutes of trading today with the intra-day H at 7.20 It is still trading at 6.71 at present (up 10.18%) with volume already more than 3x its daily average. siliconinvestor.com siliconinvestor.com After closing above 7 XOMA still shows a good amount of resistance from the 8.5 to the 9.10 level, before it can test its mid-February H at 12.15. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next